| Name | 2-(docosa-4,7,10,13,16,19-hexaenoylamino)acetic acid |
|---|---|
| Synonyms |
Glycine, N-[(4Z,7Z,10Z,13Z,16Z,19Z)-1-oxo-4,7,10,13,16,19-docosahexaen-1-yl]-
N-[(4Z,7Z,10Z,13Z,16Z,19Z)-4,7,10,13,16,19-Docosahexaenoyl]glycine |
| Description | Docosahexaenoyl glycine is a PUFA analogue. Docosahexaenoyl glycine has activating effects on IKs?channels?and restore the function of IKs?channels with LQT1 mutation[1]. |
|---|---|
| Related Catalog | |
| Target |
IC50: IKs?Channel[1] |
| References |
| Density | 1.0±0.1 g/cm3 |
|---|---|
| Boiling Point | 582.1±50.0 °C at 760 mmHg |
| Molecular Formula | C24H35NO3 |
| Molecular Weight | 385.54 |
| Flash Point | 305.9±30.1 °C |
| Exact Mass | 385.261688 |
| PSA | 66.40000 |
| LogP | 5.65 |
| Vapour Pressure | 0.0±3.5 mmHg at 25°C |
| Index of Refraction | 1.526 |